Chicago Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.43M Buy
31,078
+6,011
+24% +$485K 0.06% 129
2026
Q1
$2.17M Buy
25,067
+2,625
+12% +$251K 0.06% 129
2025
Q4
$2.16M Buy
22,442
+1,694
+8% +$165K 0.05% 135
2025
Q3
$1.98M Buy
20,748
+3,875
+23% +$356K 0.05% 138
2025
Q2
$1.47M Buy
16,873
+5,249
+45% +$445K 0.04% 154
2025
Q1
$1.04M Buy
11,624
+7,024
+153% +$629K 0.03% 171
2024
Q4
$367K Buy
4,600
+1,340
+41% +$116K 0.01% 249
2024
Q3
$294K Buy
3,260
+712
+28% +$59.9K 0.01% 268
2024
Q2
$201K Buy
+2,548
New +$209K 0.01% 299
2024
Q1
Sell
-2,437
Closed -$201K 297
2023
Q4
$201K Buy
+2,437
New +$186K 0.01% 266
2023
Q3
Sell
-2,469
Closed -$218K 229
2023
Q2
$218K Buy
+2,469
New +$213K 0.01% 214
2022
Q3
Sell
-2,541
Closed -$228K 240
2022
Q2
$228K Hold
2,541
0.01% 221
2022
Q1
$282K Hold
2,541
0.01% 217
2021
Q4
$263K Buy
2,541
+98
+4% +$11.3K 0.01% 221
2021
Q3
$306K Buy
2,443
+443
+22% +$57.3K 0.01% 212
2021
Q2
$248K Hold
2,000
0.01% 219
2021
Q1
$236K Sell
2,000
-55
-3% -$6.45K 0.01% 223
2020
Q4
$241K Buy
+2,055
New +$226K 0.01% 214
2020
Q1
Sell
-1,821
Closed -$207K 213
2019
Q4
$207K Buy
+1,821
New +$200K 0.01% 207

Other funds holding MDT

Chicago Capital's MDT Position: Q2 2026 in Review

Chicago Capital increased its Medtronic (MDT) stake by 24% in Q2 2026, buying an estimated $485K and bringing the position to 31,078 shares worth $2.43M. The position accounts for 0.06% of the portfolio, ranked #129.

Chicago Capital first reported a position in MDT in Q4 2019 and has held it in 19 quarters since. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Chicago Capital held 31,078 shares of Medtronic worth $2.43M as of Q2 2026.
  • Chicago Capital bought 6,011 Medtronic shares in Q2 2026, an estimated $485K.
  • Medtronic made up 0.06% of Chicago Capital's portfolio in Q2 2026, its #129 holding.
  • Chicago Capital first reported a position in Medtronic in Q4 2019 and has held it in 19 quarters since.
  • 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Chicago Capital's 13F filing for Q2 2026, filed 28 Jul 2026.